Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
foslevodopa, Quantity: 2400 mg; foscarbidopa, Quantity: 120 mg
Abbvie Pty Ltd
Injection, solution
Excipient Ingredients: hydrochloric acid; water for injections; sodium hydroxide
Subcutaneous
7 x 10 mL vials
(S4) Prescription Only Medicine
For the treatment of advanced idiopathic Parkinson?s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.
Visual Identification: Solution may vary from colourless to yellow to brown and may have a purple or red tint. It is clear to slightly opalescent and free from particulates.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 20 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered